In the fourth quarter of 2015, VEXIM's sales reached $4.58 million, a 44 percent increase from the same period the year prior.
Here are five takeaways:
1. This quarter's sales are VEXIM's highest number of sales since the company's inception in 2006.
2. The company's sales growth grew 24 percent in the first half of 2015 to 44 percent in the second half.
3. In 2015, VEXIM sold 10,000 Spine Jack implants.
4. VEXIM expects to expand in Europe at an approximate annual growth rate of 30 percent.
5. "Our sales performance and penetration of the spine trauma market remain strong. As we celebrate this year, the 10th anniversary of the creation of Vexim, our growth perspectives are as strong as they have ever been, in Europe and beyond," said Vincent Gardès, CEO of VEXIM. "We remain fully confident in our ability to achieve our goal of becoming a recognized global leader in the spine trauma market."
More articles on devices:
Medtech revenue up 168%: 5 insights
University of Delaware receives magnet for enhanced imaging of brain: 3 things to know
Flowers Hospital in Alabama installs Stealth system: 4 points